← Back to Clinical Trials
Recruiting NCT06699381

NCT06699381 Spinal Straightness, Posture And Balance, Physical Performance And Energy Consumption In Individuals With Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06699381
Status Recruiting
Phase
Sponsor Kırıkkale University
Condition Stroke
Study Type OBSERVATIONAL
Enrollment 30 participants
Start Date 2024-03-05
Primary Completion 2025-06-18

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 75 Years
Study Type OBSERVATIONAL
Interventions
use of spinal mouseBrunnstrom's Hemiplegia Recovery StagingThe six minute walking test (6MWT)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 30 participants in total. It began in 2024-03-05 with a primary completion date of 2025-06-18.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Patients diagnosed with ischemic or hemorrhagic stroke who applied to Kırıkkale University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation will be included in the study. The aim of our study is to investigate the relationship between spinal alignment, posture and weight transfer symmetry with balance, physical performance and energy expenditure in stroke patients.

Eligibility Criteria

Inclusion Criteria: * Individuals between the ages of 18-75 years diagnosed with stroke * Volunteering to participate in the study * Diagnosis of hemorrhagic or ischemic stroke, * No collaboration and communication problems * Can walk with assistive device or independently Exclusion Criteria: * Have another neurological, cardiopulmonary or orthopedic problem other than stroke that may affect functionality, ambulation and balance * Patients who refused to participate in the study and did not give written consent. * Cooperation and communication problems were determined as

Contact & Investigator

Central Contact

Saniye Arslan, Assoc.Prof.

✉ fztsaniye1982@gmail.com

📞 +90 5053333457

Principal Investigator

Saniye Arslan, Assoc.Prof.

PRINCIPAL INVESTIGATOR

Kırıkkale University

Frequently Asked Questions

Who can join the NCT06699381 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06699381 currently recruiting?

Yes, NCT06699381 is actively recruiting participants. Contact the research team at fztsaniye1982@gmail.com for enrollment information.

Where is the NCT06699381 trial being conducted?

This trial is being conducted at Kirikkale, Turkey (Türkiye).

Who is sponsoring the NCT06699381 clinical trial?

NCT06699381 is sponsored by Kırıkkale University. The principal investigator is Saniye Arslan, Assoc.Prof. at Kırıkkale University. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology